Aditxt, INC

Aditxt, Inc. has amended its Note Purchase Agreement, adding a new investor and issuing additional senior secured notes while canceling an existing note, maintaining the aggregate principal amount.

The Nasdaq Hearings Panel has denied Aditxt, Inc.'s request for continued listing, resulting in a suspension of trading effective June 25, 2026.

Aditxt, Inc. has entered into a definitive agreement to spin off its subsidiary, Ignite Proteomics, into a new publicly traded company via a merger with Copley Acquisition Corp.

Aditxt, Inc. has entered into a Note Purchase Agreement to issue senior secured convertible notes, consolidating existing debt and raising new capital.

Aditxt, Inc. announced the appointment of Jeffrey M. Busch as Interim CEO, replacing Amro Albanna, and detailed other executive and director resignations.

Aditxt, Inc. has received notice of non-compliance with Nasdaq stockholders' equity requirements, adding to existing delisting threats.

Aditxt, Inc. reported a substantial net loss of $16.19 million for the first quarter of 2026, with minimal revenue and ongoing concerns about its ability to continue as a going concern.

Aditxt, Inc. reports a significant net loss and negative cash flow for Q3 2025, raising substantial doubt about its ability to continue as a going concern.

Aditxt, Inc. reported a significant net loss and negative cash flow for Q2 2025, raising substantial doubt about its ability to continue as a going concern, despite recent capital raises.

Aditxt, Inc.'s Q1 2025 results reveal a net loss and going concern uncertainty, despite ongoing efforts to secure funding and strategic acquisitions.

Aditxt Inc. reports a net loss of $29.47 million for the nine months ended September 30, 2024, while navigating significant financial challenges and strategic transactions.

Aditxt Inc. reported a significant net loss for Q2 2024 and highlighted substantial doubts about its ability to continue as a going concern, while also detailing ongoing strategic transactions and financial challenges.

Aditxt, Inc. reports substantial net losses and negative cash flow for fiscal year 2025, raising significant doubt about its ability to continue as a going concern, despite ongoing product development and capital raising efforts.

Aditxt reported widening losses and received a Nasdaq delisting notice for its low stock price, casting substantial doubt on its ability to continue as a going concern despite ongoing acquisitions and financing efforts detailed in its annual report.

Aditxt, Inc.'s 2023 annual report reveals a significant net loss and raises substantial doubt about the company's ability to continue as a going concern.

Takeover Time 2026 LLC, a 10% owner and director of Aditxt, Inc., reported the acquisition of 3,420,439 shares of common stock on June 23, 2026.

HRT Financial LP reports significant transactions in Aditxt, Inc. common stock, including acquisitions and dispositions.

Tai Wey Ann updates beneficial ownership filing for Aditxt, Inc. (ADTX) due to updated outstanding share count.

HRT Financial LP has reported a significant change in its beneficial ownership of Aditxt, Inc. Class A Shares.

DRW Securities, LLC, a 10% owner, has reported a transaction involving common stock of Aditxt, Inc. (ADTX).

HRT Financial LP reported significant transactions involving Aditxt, Inc. common stock, including the acquisition and disposal of shares.

Aditxt Inc. has issued a definitive proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for May 1, 2026, detailing proposals including director elections, auditor ratification, executive compensation votes, and a significant reverse stock split authorization.

Aditxt, Inc. calls a Special Meeting to approve a reverse stock split, a corporate name change to bitXbio, Inc., and the issuance of shares related to past financings and new employee equity plans.

Aditxt, Inc. outlines a transformative bitXbio strategy, proposing a name change to bitXbio, Inc., an Employee Stock Purchase Plan, and updates on Pearsanta's planned IPO and Evofem's uplisting efforts.

Aditxt, Inc. has filed definitive additional materials related to a proxy statement with the U.S. Securities and Exchange Commission.

Aditxt, Inc. announced its 2025 Annual Meeting, proposing a reverse stock split to meet Nasdaq listing requirements and revealing significant reliance on insider loans.

Aditxt is convening a special meeting to seek stockholder approval for several proposals, including the issuance of common stock related to convertible preferred stock and warrants, and a reverse stock split.

Aditxt, Inc. has filed an S-1 registration statement to allow for the resale of up to 50 million common shares by Seven Knots, LLC, while outlining its strategy to raise up to $150 million through direct sales to Seven Knots, with proceeds earmarked for debt redemption, acquisitions, and a new digital asset treasury strategy focused on bitcoin.

Aditxt, Inc. has filed an amendment to convert its registration statement from Form S-3 to Form S-1, paving the way for the potential resale of up to $150 million of its common stock by Seven Knots, LLC.

Aditxt, Inc. files an amendment to its Form S-1 registration statement to facilitate the resale of up to 3,785,569 shares of common stock by a selling stockholder.

Aditxt, Inc. files an amendment to its S-1 registration statement, detailing the potential resale of 3,785,569 shares of common stock by a selling stockholder and the possibility of generating $12.3 million through warrant exercises.

Aditxt, Inc. files an amendment to its registration statement for the resale of up to 3,785,569 shares of common stock by a selling stockholder.

Aditxt, Inc. has filed an amendment to its registration statement for the resale of up to 3,785,569 shares of common stock by a selling stockholder.

Takeover Time 2026 LLC has reported the total divestment of its entire stake in Aditxt, Inc. as of June 23, 2026.

Christopher Castillo has filed a Schedule 13G, reporting beneficial ownership of 62,000 shares, representing 6.2% of Aditxt, Inc.'s common stock.

Christopher Castillo has filed a Schedule 13G, reporting beneficial ownership of 75,000 shares, representing 9.19% of Aditxt, Inc.'s common stock.

Individual investor Jerzy Stanislaw Wojcik has filed a Schedule 13G reporting a 19.6% beneficial ownership stake in Aditxt, Inc.

Individual investor Tai Wey Ann reports beneficial ownership of 100,000 shares of Aditxt, Inc. common stock.

Jonathan Edward Hester reports zero beneficial ownership of Aditxt, Inc. common stock in this Schedule 13G filing.

Andy Ni has filed an amendment to his Schedule 13G, disclosing that he no longer holds any beneficial ownership in Aditxt, Inc. common shares.